<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02746107</url>
  </required_header>
  <id_info>
    <org_study_id>Studiul Cozia</org_study_id>
    <nct_id>NCT02746107</nct_id>
  </id_info>
  <brief_title>Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.</brief_title>
  <official_title>RCT Concerning the Intention to Prescribe/Take Oral Anticoagulants for Atrial Fibrillation Depending on the Number of Risk Diagrams (w Treatment +/- w/Out Treatment), and Number of Years (1 or 5) for the Estimation of the Risk of Stroke.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cristian Baicus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carol Davila University of Medicine and Pharmacy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized study concerning the effect of the number of risk diagrams (with treatment +/-
      without treatment), the period of stroke risk estimation (one year or five years) and the
      target of prescription (the patient with atrial fibrillation or the physician himself,
      imagining she/he has atrial fibrillation) on the intention to prescribe or not oral
      anticoagulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      To answer the questions:

        1. Concerning the decision to prescribe (take) treatment on the basis of a decision aid,
           are there necessary both diagrams (that with risk without treatment, and that with risk
           under treatment), or it is enough only the second (risk under treatment, which normally
           gives all the needed information)?

        2. Concerning the decision to prescribe (take) treatment, is it a difference between the
           effects of the presentation on decision aid of the risk of stroke for the next 1 year,
           and the presentation of the estimated risk of stroke for the next 5 years?

        3. Is the decision different if physicians prescribe the anticoagulant treatment to
           patients, over if they should take it themselves?

      Study: 2x3 factorial randomized controlled trial (RCT) for comparison:

        1. Between the decision aid with 2 images (without treatment + with treatment) and the one
           with 1 image (risk only with treatment)

        2. Between the effect of the presentation of the stroke risk chart for 1 year and the
           stroke risk chart for 5 years.

        3. The decision to prescribe to patients over the decision to take the treatment
           themselves.

      The comparison will be made for the spectrum of risks (scores CHA2DS2-VASC) from 1-5.

      Sample size: was calculated a sample of 948 participants (474 + 474) for p = 0.05, power =
      80% statistical difference between decisions of 5% (from 95% to 90%). The study does not have
      enough power neither to compare the 5 groups CHA2DS2-VASC (but we will make these comparisons
      with exploratory purpose), nor to test interactions.

      Participants: physicians participating to the National Congress of Internal Medicine,
      physicians participating to courses, professional manifestations.

      Randomization: randomization will be done on graph type (1 or 2 pictures), duration of risk
      estimate (1 year and 5 years) and the size of CHA2DS2-VASC risk score (1 to 5), and target
      prescription (patient or the doctor himself), a total of 40 possibilities. Randomization will
      be done in blocks of 40.

      Participants will be asked to decide, depending on the risk chart, if the patient (or
      himself) will be treated, ignoring the risk of bleeding.

      The chart will contain the pictogram according to the CHA2DS2-VASC risk score, without
      communicating the actual score, and the physician will have to make the decision to treat or
      not, depending on the perceived risk, and not on treatment guidelines.

      No. questionnaire: first digit = number of risk diagrams (1 or 2); second digit = number of
      years for which the risk of stroke is calculated (1 or 5); third digit = CHA2DS2-VASC score
      (1-5). Ex: 253: 2 decision aid diagrams (with and without treatment), with an estimated risk
      of stroke for the next five years, in a patient with CHA2DS2-VASC score =3.

      Effect (outcome): decision to treat / not to treat the patient / physician himself, with oral
      anticoagulants.

      Statistical analysis: It will look for differences in bivariate analysis, and multivariate =
      logistic regression (dependent variable = treatment decision, the independent variables =
      number of charts, period for risk assessment (one or 5 years), prescription target (patient
      or the physician himself), CHA2DS2-VASC score, time from graduation, medical/teaching grade,
      working in hospital / ambulatory, the size of the city the physician works in, specialty,
      gender, age, if the physician has/had someone close with stroke (data from questionnaires).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams</measure>
    <time_frame>after seeing the decision aid (5 min)</time_frame>
    <description>after regarding the risk diagram, the physician will decide to prescribe/take or not the treatment</description>
  </primary_outcome>
  <other_outcome>
    <measure>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Timeframe for Risk Presentation (1 vs 5 Years)</measure>
    <time_frame>5 minutes</time_frame>
    <description>the proportion of physicians deciding to prescribe OAC after seeing risk estimation on 1 vs 5 years</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Target of Prescription (Patient vs. Physician Himself)</measure>
    <time_frame>5 min</time_frame>
    <description>the participant physicians were randomized to prescribe to virtual patients or to imagine that the risk seen in the diagram was that of themselves</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the CHA2D2s-VASC Risk Score</measure>
    <time_frame>5 min</time_frame>
    <description>The proportion of OAC prescription for the range 1-5 of CHA2D2s-VASC scores. CHA2D2S-VASC risk score ranges from 1-5, with higher scores indicating a greater risk of stroke.</description>
  </other_outcome>
  <number_of_arms>11</number_of_arms>
  <enrollment type="Actual">968</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>risk presented on 1 diagram</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>decision aid with risk of stroke presented on 1 diagram (risk under OAC treatment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>risk presented on 2 diagrams</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>decision aid with risk of stroke presented on 2 diagrams (one presenting risk without and one presenting risk with treatment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1year risk estimate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>risk of stroke presented over a timeframe of 1 year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5year risk estimate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>risk of stroke presented over a timeframe of 5 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHA2DS2-VASC risk score 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CHA2DS2-VASC risk score =1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHA2DS2-VASC risk score 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CHA2DS2-VASC risk score =2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHA2DS2-VASC risk score 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CHA2DS2-VASC risk score =3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHA2DS2-VASC risk score 4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CHA2DS2-VASC risk score =4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHA2DS2-VASC risk score 5</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CHA2DS2-VASC risk score =5</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prescription to virtual patient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prescription is done for a virtual patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prescription to physician himself</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prescription is done to physician himself</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>decision aid</intervention_name>
    <description>decision aid with one/two diagrams decision aid with risk over one/five years decision aid with CHA2DS2-VASC risk score 1 to 5 target of the prescription: patient / physician hinself</description>
    <arm_group_label>risk presented on 1 diagram</arm_group_label>
    <arm_group_label>risk presented on 2 diagrams</arm_group_label>
    <arm_group_label>1year risk estimate</arm_group_label>
    <arm_group_label>5year risk estimate</arm_group_label>
    <arm_group_label>CHA2DS2-VASC risk score 1</arm_group_label>
    <arm_group_label>CHA2DS2-VASC risk score 2</arm_group_label>
    <arm_group_label>CHA2DS2-VASC risk score 3</arm_group_label>
    <arm_group_label>CHA2DS2-VASC risk score 4</arm_group_label>
    <arm_group_label>CHA2DS2-VASC risk score 5</arm_group_label>
    <arm_group_label>prescription to virtual patient</arm_group_label>
    <arm_group_label>prescription to physician himself</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  physicians who prescribe anticoagulant treatment for atrial fibrillation (cardiology,
             internal medicine, family medicine, hematology) or who deal with patients with stroke
             (neurology, pathology) or bleeding (gastroenterology)

        Exclusion Criteria:

          -  physicians who never prescribe anticoagulant treatments, or do not deal with patients
             with stroke or bleeding because of anticoagulants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristian Baicus, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Carol Davila University of Medicine and Pharmacy Bucharest - Colentina Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Colentina Clinica Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2016</study_first_submitted>
  <study_first_submitted_qc>April 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2016</study_first_posted>
  <results_first_submitted>June 9, 2016</results_first_submitted>
  <results_first_submitted_qc>September 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2016</results_first_posted>
  <last_update_submitted>September 13, 2016</last_update_submitted>
  <last_update_submitted_qc>September 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Carol Davila University of Medicine and Pharmacy</investigator_affiliation>
    <investigator_full_name>Cristian Baicus</investigator_full_name>
    <investigator_title>Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>shared decision making</keyword>
  <keyword>oral anticoagulant</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>stroke</keyword>
  <keyword>decision to treat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>At the end, when published</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Study Participants</title>
          <description>all study participants were 968 (in all arms of this factorial RCT)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="968"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>2 Diagrams DA</title>
              <participants_list>
                <participants group_id="P1" count="482"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1 Diagram DA</title>
              <participants_list>
                <participants group_id="P1" count="486"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1year Risk Estimate</title>
              <participants_list>
                <participants group_id="P1" count="483"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>5year Risk Estimate</title>
              <participants_list>
                <participants group_id="P1" count="485"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Target=Patient</title>
              <participants_list>
                <participants group_id="P1" count="486"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Target=Physician</title>
              <participants_list>
                <participants group_id="P1" count="482"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CHA2DS2-VASC Score = 1</title>
              <participants_list>
                <participants group_id="P1" count="195"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CHA2DS2-VASC Score = 2</title>
              <participants_list>
                <participants group_id="P1" count="189"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CHA2DS2-VASC Score = 3</title>
              <participants_list>
                <participants group_id="P1" count="195"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CHA2DS2-VASC Score = 4</title>
              <participants_list>
                <participants group_id="P1" count="197"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CHA2DS2-VASC Score = 5</title>
              <participants_list>
                <participants group_id="P1" count="192"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="968"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>age: median (min, max): 39 (25, 83)</population>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>all participants in the study (968)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="968"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39" lower_limit="25" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Romania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="968"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams</title>
        <description>after regarding the risk diagram, the physician will decide to prescribe/take or not the treatment</description>
        <time_frame>after seeing the decision aid (5 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One Diagram</title>
            <description>decision aid with one diagram (risk under treatment)
decision aid: decision aid with one/two diagrams</description>
          </group>
          <group group_id="O2">
            <title>Two Diagrams</title>
            <description>classical decision aid with 2 diagrams (risk without treatment, and risk with treatment)
decision aid: decision aid with one/two diagrams</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams</title>
          <description>after regarding the risk diagram, the physician will decide to prescribe/take or not the treatment</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="400"/>
                    <measurement group_id="O2" value="406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>details provided in the protocol. Noninferiority margin=+/-5%</non_inferiority_desc>
            <p_value>0.83</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4</ci_lower_limit>
            <ci_upper_limit>5.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Timeframe for Risk Presentation (1 vs 5 Years)</title>
        <description>the proportion of physicians deciding to prescribe OAC after seeing risk estimation on 1 vs 5 years</description>
        <time_frame>5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5 Years Risk Estimation on DA</title>
            <description>participants had to prescribe or not OAC after seeing the risk estimated on 5 years</description>
          </group>
          <group group_id="O2">
            <title>1 Year Risk Estimation on DA (CHA2D2S-VASC Score)</title>
            <description>participants deciding to prescribe or not OAC after seeing the stroke risk estimation on 1 year (classical CHA2D2S-VASC score)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Timeframe for Risk Presentation (1 vs 5 Years)</title>
          <description>the proportion of physicians deciding to prescribe OAC after seeing risk estimation on 1 vs 5 years</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="485"/>
                <count group_id="O2" value="483"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="412"/>
                    <measurement group_id="O2" value="394"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>details provided in protocol;</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.187</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>3.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.3</ci_lower_limit>
            <ci_upper_limit>8.1</ci_upper_limit>
            <estimate_desc>(risk on 5y) - (risk on 1y)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Target of Prescription (Patient vs. Physician Himself)</title>
        <description>the participant physicians were randomized to prescribe to virtual patients or to imagine that the risk seen in the diagram was that of themselves</description>
        <time_frame>5 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prescription to Patient</title>
            <description>the participant physician were randomized to prescribe OAC to virtual patients</description>
          </group>
          <group group_id="O2">
            <title>Prescription to Physician Himself</title>
            <description>the participants had to imagine that they had atrial fibrillation, the risk from the diagram was theirs, and had to decide to take or not the OACs</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Target of Prescription (Patient vs. Physician Himself)</title>
          <description>the participant physicians were randomized to prescribe to virtual patients or to imagine that the risk seen in the diagram was that of themselves</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="442"/>
                    <measurement group_id="O2" value="364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>15.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>10.8</ci_lower_limit>
            <ci_upper_limit>20</ci_upper_limit>
            <estimate_desc>patient - (physicians themselves)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Regression, Logistic</method>
            <method_desc>adjustment for age, gender, CHA2D2s-VASC score, nr of diagrams, nr of years, presence of someone close with stroke, graduation year, speciality</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.28</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.25</ci_lower_limit>
            <ci_upper_limit>4.78</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the CHA2D2s-VASC Risk Score</title>
        <description>The proportion of OAC prescription for the range 1-5 of CHA2D2s-VASC scores. CHA2D2S-VASC risk score ranges from 1-5, with higher scores indicating a greater risk of stroke.</description>
        <time_frame>5 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CHA2D2S-VASC Risk Score 1</title>
          </group>
          <group group_id="O2">
            <title>CHA2D2S-VASC Risk Score 2</title>
          </group>
          <group group_id="O3">
            <title>CHA2D2S-VASC Risk Score 3</title>
          </group>
          <group group_id="O4">
            <title>CHA2D2S-VASC Risk Score 4</title>
          </group>
          <group group_id="O5">
            <title>CHA2D2S-VASC Risk Score 5</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the CHA2D2s-VASC Risk Score</title>
          <description>The proportion of OAC prescription for the range 1-5 of CHA2D2s-VASC scores. CHA2D2S-VASC risk score ranges from 1-5, with higher scores indicating a greater risk of stroke.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="195"/>
                <count group_id="O2" value="189"/>
                <count group_id="O3" value="195"/>
                <count group_id="O4" value="197"/>
                <count group_id="O5" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="159"/>
                    <measurement group_id="O3" value="164"/>
                    <measurement group_id="O4" value="172"/>
                    <measurement group_id="O5" value="165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CHA2D2S-VASC risk score 1 was the reference</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.034</p_value>
            <method>Chi-squared</method>
            <method_desc>CHA2D2S-VASC risk score 1 was reference</method_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>9.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>17</ci_upper_limit>
            <estimate_desc>positive value means higher proportion of prescription, CHA2D2S-VASC risk score 1 was reference</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.033</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>9.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>17</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>12.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.7</ci_lower_limit>
            <ci_upper_limit>20.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>11.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.2</ci_lower_limit>
            <ci_upper_limit>18.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>CHA2D2S-VASC risk score 1 was the reference</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.024</p_value>
            <method>Regression, Logistic</method>
            <method_desc>CHA2D2S-VASC risk score 1 was the reference, adjusted for nr diagrams, nr years, age, gender, smb close with stroke, speciality, professional degree</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.08</ci_lower_limit>
            <ci_upper_limit>3.07</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Adjusted for age, gender, medical and academic degrees, someone close with stroke, speciality, period of risk estimation, number of figures.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.77</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.06</ci_lower_limit>
            <ci_upper_limit>2.98</ci_upper_limit>
            <estimate_desc>numerator: CHADS-VASC 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Adjusted for age, gender, medical and academic degrees, someone close with stroke, speciality, period of risk estimation, number of figures.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.37</ci_lower_limit>
            <ci_upper_limit>4.09</ci_upper_limit>
            <estimate_desc>numerator = CHADS-VASC 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>Regression, Logistic</method>
            <method_desc>Adjusted for age, gender, medical and academic degrees, someone close with stroke, speciality, period of risk estimation, number of figures.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.19</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.14</ci_lower_limit>
            <ci_upper_limit>2.56</ci_upper_limit>
            <estimate_desc>numerator=CHADS-VASC 1</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>One Diagram</title>
          <description>decision aid with one diagram (risk under treatment)
decision aid: decision aid with one/two diagrams
OAC prescribed: 400 of 486 (83%)</description>
        </group>
        <group group_id="E2">
          <title>Two Diagrams</title>
          <description>classical decision aid with 2 diagrams (risk without treatment, and risk with treatment)
decision aid: decision aid with one/two diagrams
OAC prescribed: 406 of 482 (83.5%)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="486"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="482"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="486"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="482"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>prescription was only simulated - not real patients, physicians had to imagine they had atrial fibrillation
results could be different on patients
participants had to decide prescription/not after seeing the risk diagram for only 5 minutes</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Professor Cristian Baicus</name_or_title>
      <organization>Carol Davila University of Medicine and Pharmacy Bucharest</organization>
      <phone>+40788302355</phone>
      <email>cbaicus@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

